OptimizeRx Corp

Ownership Transactions Reported by 17 Insiders

Symbol
OPRX on Nasdaq
Industry
Services-Business Services, NEC
Location
260 Charles Street, Suite 302, Waltham, MA

Insiders trading volume in the past year

OptimizeRx Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Febbo CEO, Director $4.61M +$100K +2.22% Feb 14, 2025
James Paul Lang Director $4.4M +$2.44M +125% Jun 11, 2025
Stephen L. Silvestro Chief Executive Officer $3.54M -$30.4K -0.85% Oct 3, 2025
Edward Stelmakh Chief Finance & Strat Officer $2.42M Oct 3, 2025
Marion Odence-Ford Chief Legal & Admin Officer $1.7M Oct 3, 2025
Miriam Paramore President And Cso $1.67M Dec 2, 2021
Doug Besch Chief Product & Tech Officer $1.35M Oct 3, 2025
Theresa Greco Chief Commercial Officer $1.29M Aug 21, 2025
Andrew J. D'Silva Chief Business Officer $974K Aug 21, 2025
Gus D. Halas Director $866K Jun 5, 2024
Douglas P. Baker Chief Financial Officer $854K Oct 5, 2021
Ellen O'Connor Vos Director $800K Jun 11, 2025
Gregory D. Wasson Director $630K Jun 11, 2025
Patrick D. Spangler Director $609K -$194K -24.2% Aug 28, 2025
Cathy Klema Director $238K Jun 11, 2025
Todd Inman Chief Technology Officer $177K Mar 1, 2023
Brian Clark McCarthy Chief Revenue Officer $102K Aug 2, 2024

Recent Insider Transactions by Companies or Individuals for OptimizeRx Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.